Publication: Effects of antileukotriene among asthmatic patients
Issued Date
2001-05-01
Resource Type
ISSN
01252208
Other identifier(s)
2-s2.0-0034797814
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the Medical Association of Thailand. Vol.84, No.5 (2001), 719-722
Suggested Citation
Sawang Saenghirunvattana Effects of antileukotriene among asthmatic patients. Journal of the Medical Association of Thailand. Vol.84, No.5 (2001), 719-722. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/26789
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Effects of antileukotriene among asthmatic patients
Author(s)
Other Contributor(s)
Abstract
Study objective: To determine the effect of antileukotriene (montelukast) 10 mg once daily for the treatment of mild to moderate asthma. Design: Open label, prospective. Patients: Thirty asthmatic patients ≥18 years of age with baseline FEV1>60 per cent and ≤80 per cent of predicted values and evidence of reversible airway obstruction, as defined by an increase in FEV1 of ≥20 per cent. Interventions: Montelukast 10 mg once daily orally for 12 weeks, back up beta-2 agonist inhaler was available. Measurement and results: Spirometry was performed during the screening period, and every month after starting antileukotriene. Subjects recorded asthma-related symptoms and use of supplement beta-2 agonists daily on diary cards. Over 12 weeks of treatment, the FEV1 increased 10 per cent, 14 per cent and 19 per cent respectively, compared to the baseline (p<0.05). The physician and patients evaluation scores were quite good in the study. Conclusion: Oral montelukast once daily gave a favorable effect in management of mild to moderate asthmatic patients.
